Postpartum hemorrhage (PPH) is the most prevalent type of obstetric hemorrhage and one of the primary causes of maternal mortality. Blood loss from vaginal or cesarean delivery is known as PPH.
New York, June 28, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Postpartum Hemorrhage Devices Market Size, Share & Industry Trends Analysis Report By Product, By Regional Outlook and Forecast, 2022 – 2028" - https://www.reportlinker.com/p06289281/?utm_source=GNW Postpartum hemorrhage is classified based on the amount of blood lost. Blood loss of less than 500 mL is considered primary PPH, while blood loss of more than 500 mL is considered secondary PPH. Modern PPH treatment devices outperform previous procedures since they are designed to treat uterine diseases and difficulties with uterine contractions. PPH devices are non-pneumatic anti-shock garments, uterine balloon tamponade, and inject prefilled injectable systems that are used as second-line intervention devices. These devices are helpful in stopping blood flow and stabilizing the patient’s condition until more serious medical help arrives. Uterine atony, a disease in which the uterus fails to contract following the birth of the baby, is the most prevalent cause of PPH. First response interventions, such as uterotonic drugs (primarily oxytocin), isotonic crystalloids, tranexamic acid, and uterine massage; and, if necessary, refractory PPH interventions, such as compressive measures (aortic compression or bimanual uterine compression), intrauterine balloon tamponade, and nonpneumatic anti shock garment (NASG). Surgical intervention (compressive sutures, artery ligation, or hysterectomy) is required if these methods fail. In 2012, the World Health Organization (WHO) issued a conditional recommendation in favor of uterine balloon tamponade (UBT) in cases when uterotonics were unavailable or ineffective in reducing bleeding. COVID-19 Impact The COVID-19 pandemic wrought havoc on people’s health and the economy around the world. It has had an impact on entire economies and businesses, as well as individual careers and lives. The outbreak also led to the unfortunate demise of millions across the world. As enterprises turn their focus away from development prospects and onto implementing exceptional measures to avoid the harmful impact of the COVID-19 pandemic, the stress of maintaining revenue levels at pre-COVID levels has become the new normal. The postpartum hemorrhage devices market is expected to rise in response to the COVID-19 outbreak. Covid-19 infection raises the risk of pregnancy complications such as postpartum hemorrhage, which helps the market grow by increasing the number of PPH patients. Market Growth Factors Rise in Complications Like Obstetric Hemorrhage The postpartum hemorrhage devices market is growing due to a rise in complications such as acute postpartum hemorrhage. The most common and dangerous complication of childbirth is obstetric hemorrhage. Postpartum hemorrhage (PPH) is traditionally described as a blood loss of more than 500 mL estimated with a vaginal delivery or more than 1000 mL estimated during a cesarean delivery. The American College of Obstetrics and Gynecology characterized this in 2017 as an accumulation of blood loss of more than 1000 mL with signs and symptoms of hypovolemia within 24 hours after the birth procedure, regardless of delivery mode. Growing Investment in Healthcare Sector in Developed and Developing Countries Governments of developing countries such as India and China are investing heavily in the healthcare sector of their respective countries. In 2020, for instance, the Indian health tech business was estimated to be worth $1.9 billion. It is predicted to reach $ 5 billion by 2023, with a CGAR of 39%. The Indian digital healthcare market was worth USD 1.50 billion in 2018 and is expected to grow to USD 6.26 billion by 2024. The expansion of the healthcare business is likely to positively impact the postpartum hemorrhage devices market. Even in developed countries, such as the United States, governments are spending enormous amounts to modernize and expand the healthcare sector. Market Restraining Factors Inaccuracies in Measuring Blood Loss in Obstetric Hemorrhage Postpartum hemorrhage is the leading cause of maternal death in the United States, accounting for about 11% of all maternal deaths. Significantly, obstetric hemorrhage is responsible for 54-93% of maternal deaths. Health care providers’ inaccurate estimation of actual blood loss at the time of birth and in the immediate postpartum period is a major cause of delayed hemorrhage response, according to studies. Underestimations of blood loss lead healthcare providers into believing that deployment of postpartum hemorrhage are not necessary, thus, limiting the use of postpartum hemorrhage devices. Product Outlook Based on Product, the market is segmented into Uterine Tamponade Devices, Prefilled Injection System, and Non-Pneumatic Anti-Shock Garment. The uterine tamponade devices segment acquired the largest revenue share in the postpartum hemorrhage devices market in 2021. This is due to the device’s ability to work quickly and reduce the need for risky and expensive surgical procedures. Furthermore, the device is quick responding and less intrusive, making it a safe way to manage PPH. Moreover, since the gadget kit contains few pieces, it can be installed quickly and easily, increasing its efficacy. Regional Outlook Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa. The Asia Pacific acquired the highest revenue share in the postpartum hemorrhage devices market in 2021. Government initiatives to reduce maternal deaths and enable access to preferred therapy for effective management throughout the third phase of labor are projected to benefit the Asia-Pacific market even more and raise the demand for PPH devices in the upcoming years. Furthermore, the region’s dearth of skilled caretakers, operating skills, and blood-transfusion facilities are expected to fuel the demand for PPH treatment devices. The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Teleflex, Inc., Becton, Dickinson and Company, Bactiguard Holding AB, Utah Medical Products, Inc., Organon & Co., Cook Medical, Inc., PATH, Obstetrx, Inc., Zoex Corporation, and 3rd Stone Design, Inc. Scope of the Study Market Segments covered in the Report: By Product • Uterine Tamponade Devices • Prefilled Injection System • Non-Pneumatic Anti-Shock Garment By Geography • North America o US o Canada o Mexico o Rest of North America • Europe o Germany o UK o France o Russia o Spain o Italy o Rest of Europe • Asia Pacific o China o Japan o India o South Korea o Singapore o Malaysia o Rest of Asia Pacific • LAMEA o Brazil o Argentina o UAE o Saudi Arabia o South Africa o Nigeria o Rest of LAMEA Companies Profiled • Teleflex, Inc. • Becton, Dickinson and Company • Bactiguard Holding AB • Utah Medical Products, Inc. • Organon & Co. • Cook Medical, Inc. • PATH • Obstetrx, Inc. • Zoex Corporation • 3rd Stone Design, Inc. Unique Offerings • Exhaustive coverage • Highest number of market tables and figures • Subscription based model available • Guaranteed best price • Assured post sales research support with 10% customization free Read the full report: https://www.reportlinker.com/p06289281/?utm_source=GNW About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________
Meta CEO Mark Zuckerberg announced to employees that the social media giant would be scaling back hiring and turning up the heat on its employees.
Shares of Nvidia (NASDAQ: NVDA) plunged this week after the company's stock received a price target cut, some analysts had a few negative comments about the chip market, and investors worried that comments made from another chip company about slowing demand might mean bad news for Nvidia as well. Investors panicked a bit on all this news and sent the semiconductor stock falling 15.3% over the past week. Nvidia started off the week with Morgan Stanley warning that there could be a potential slowdown in demand for graphics processors as Ethereum, a leading blockchain and cryptocurrency, switches to a proof-of-stake model and away from its current proof-of-work setup.
The CEO of social media giant Meta is pessimistic about the economy and is looking for ways to keep his company profitable.
The Oracle of Omaha knows how to beat inflation. So ride his coattails.
The mood has changed at the headquarters of Meta Platforms , parent of Facebook, Instagram and WhatsApp, in Menlo Park, California. For months now, many economists have been anticipating a sharp downturn in the economy due to aggressive monetary policy by the Federal Reserve and central banks around the world to combat record price increases everywhere. The Russian war in Ukraine has further exacerbated the supply chain problems caused by the Covid-19 pandemic.
The super investor still sees opportunities ahead.
Last late-week rally in the markets quickly faded and this week is ending with declines in the major stock indexes. It’s the classic patter on the dead cat bounce, a brief recovery that is followed by more losses, and it has investors worried that there is no bottom in sight. Writing from the global markets strategy team, where he takes a broader look at the worldwide market situation, JPMorgan’s Marko Kolanovic lays out the headwinds running against US investors: “First and foremost, an unprece
Oppenheimer continues to expect strong fundamentals in the U.S. banking sector, even as fears of a recession heighten.
(Bloomberg) -- Global oil prices could reach a “stratospheric” $380 a barrel if US and European penalties prompt Russia to inflict retaliatory crude-output cuts, JPMorgan Chase & Co. analysts warned.Most Read from BloombergCrypto Meltdown Claims Rolex and Patek Philippe as VictimsUS Will Face High Gas Prices ‘as Long as It Takes,’ Biden SaysHow Europe Became the Epicenter for This Summer’s Travel ChaosThe Wheels Have Come Off Electric VehiclesNetflix Crashes After ‘Stranger Things 4’ Finale Rele
A bear market leaves the S&P 500 with its worst first six months since 1970. Here's what's happened after stocks suffered steep first-half stumbles in the past.
Endo International plc (NASDAQ: ENDP) announced today that a federal jury in Chicago, Illinois, has returned a verdict in favor of the Company's subsidiaries Endo Pharmaceuticals Inc. and Endo Health Solutions Inc. (collectively Endo), in an antitrust trial.
Canadian crypto broker Voyager Digital is suspending trading including deposits and withdrawals according to a statement released by the firm Friday afternoon.
With tech stocks like Nvidia out of favor, chemicals and oil stock dominate this list of growth stocks eyeing 109%-370% gains.
(Bloomberg) -- The Apple Inc. lawyer who was once responsible for enforcing the company’s insider trading policy admitted he used his access to draft SEC filings to personally profit. Most Read from BloombergUS Will Face High Gas Prices ‘as Long as It Takes,’ Biden SaysStock Doomsayers Vindicated in Historic First Half: Markets WrapThe Wheels Have Come Off Electric VehiclesDemocrats Weigh Paring Biden Tax Hike to Win Over ManchinSupreme Court Crimps Biden’s Climate Agenda With Limits on EPAGene
Michael Burry called the stock market the “greatest speculative bubble of all time in all things” last year. Now, he’s arguing corporate earnings will take a hit, driving prices even lower.
Want to learn how to retire with $5 million? Here are a few things you can do to stretch your nest egg over the course of your retirement.
GM said chip shortages and supply chain snarls left nearly 100,000 vehicles unfinished over the second quarter.
(Bloomberg) -- A “recession shock” begins for markets following the worst first-half for the S&P 500 in more than 50 years, Bank of America Corp.’s Chief Investment Strategist Michael Hartnett says.Most Read from BloombergUS Will Face High Gas Prices ‘as Long as It Takes,’ Biden SaysCrypto Meltdown Claims Rolex and Patek Philippe as VictimsThe Wheels Have Come Off Electric VehiclesHow Europe Became the Epicenter for This Summer’s Travel ChaosStock Doomsayers Vindicated in Historic First Half: Ma
Shares of Shopify (NYSE: SHOP) plummeted 18.2% this week on several bits of news. First, shares fell earlier in the week when revised GDP figures were released, showing that the economy was slowing down slightly more than expected. Additionally, a new report released yesterday, showing that inflation remains stubbornly high despite the Federal Reserve's efforts to bring it down, is likely weighing down on the stock this week.
In this article, we discuss 10 defensive stocks that Ken Fisher loves. If you want to skip our detailed analysis of Fisher’s investment philosophy, hedge fund returns, and history, go directly to Ken Fisher Loves These 5 Defensive Stocks. Born in 1950, Kenneth Lawrence Fisher is an American investor, author, and founder of one of […]